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A
nextensiveliteraturehasdeveloped
to suggest that depression is more
common in patients with diabetes
than in the general population (1) and is
associated with chronic hyperglycemia
(2), risk for diabetes complications (3),
and mortality (4). Although the causal
linkages among these relationships have
not been demonstrated, their consistency
has led to calls for intensive efforts to
identify and treat clinical depression in
patients with diabetes, with the reason-
ablepresumptionthatthiswillcontribute
to better diabetes outcomes. Recent stud-
ies, however, suggest a more complicated
picture and cast doubt on this presump-
tion.
Although research has suggested that
the prevalence of clinical depression, or
majordepressivedisorder(MDD),among
adults with diabetes may be two to three
times greater than among community
adults (1), recent studies—which have
used structured clinical interviews, the
gold standard in the diagnosis of MDD—
suggest that it is only about 60% more
common(5).Moreimportantly,diabetes-
related distress, or signiﬁcant negative
emotionalreactionstothediagnosisofdi-
abetes, threat of complications, self-
management demands, unresponsive
providers, and/or unsupportive interper-
sonal relationships, has been found to be
far more common, more chronic, and
more closely related to diabetes self-care
and glycemic control than MDD (5–7).
Symptoms of depression, such as de-
pressed mood, diminished interest, loss
of energy, and concentration difﬁculties,
that are elevated but do not meet severity
criteria for MDD (referred to here as de-
pressive symptoms) are also quite com-
mon among patients with diabetes and
areassociatedwithpoorself-care(8).Fur-
thermore, increased risk of complications
and early mortality is not limited to those
with MDD but also extends to those with
elevated depressive symptoms, even
when these elevations are quite modest
(4).Thissuggestsanincrementalrelation-
ship between the severity of depressive
symptoms and poorer diabetes outcomes
rather than an effect of MDD per se.
There is minimal evidence for a lon-
gitudinal relationship between MDD and
hyperglycemia over time, and changes in
one over time do not appear to be associ-
ated with changes in the other (7). Nu-
merous treatment studies have shown
positive effects for the improvement of
MDD in diabetic patients, but evidence
for resulting glycemic beneﬁt is, at best,
weak (9).
The current commentary seeks to
shed light on the discontinuity among
theseﬁndings.First,wesuggestthatthere
has been considerable confusion among
MDD, diabetes-related distress, and de-
pressive symptoms. We argue that this
confusion has been exacerbated by mea-
surement problems that stem from the
lack of a clear distinction between MDD
and nonpsychiatric emotional distress.
Second, we suggest that this has led to a
narrow focus on potential intervention
approaches, originally developed for
MDD, that may be limited in their ability
to address diabetes-related distress and
depressive symptoms. Although we do
not deny the importance of true psychiat-
ric presentations of MDD among those
with diabetes, traditional approaches to
MDD treatment may be unlikely to im-
prove diabetes outcomes unless they also
incorporate strategies to address impor-
tant relationships between MDD and
chronic illness (rev. in 10). Finally, we
suggest an alternative approach to under-
standing the common experience of emo-
tionaldistressindiabetesthatemphasizes
the demanding experience of diabetes
and requires diabetes-speciﬁc measure-
ment and treatment approaches.
Have we been using the wrong
assessment approach?
There is a recurrent disconnect in the di-
abetes literature between the conceptual
basis of emotional distress and the mea-
surement methods we use. The predomi-
nant conceptual model that underlies the
current understanding of emotional dis-
tress in diabetes, whether explicit or im-
plicit, is the psychiatric diagnosis of
MDD.However,thevastmajorityofstud-
ies rely on self-report questionnaires that
assess symptoms of distress that are often
only loosely associated with the diagnos-
tic criteria for MDD. These self-report
measures have been shown to be more
reﬂective of general emotional distress
than MDD (11). Furthermore, they may
fullycapturebutinappropriatelypatholo-
gize diabetes distress and depressive
symptoms. The physical symptoms asso-
ciated with diabetes further complicate
distress assessment because they may be
mistaken for symptoms of MDD. Even
though many self-report measures have
been developed with acceptable psycho-
metricpropertiesfordetectingMDD,they
often achieve a satisfactory level of sensi-
tivity at the expense of yielding a high
percentage of false-positives (12). Thus,
diabetic patients experiencing depressive
symptoms and/or diabetes distress may
be misclassiﬁed as having MDD, espe-
ciallywhenself-reportmeasuresareused.
Studies that have used both self-
report questionnaires for depressive
symptoms and structured interviews
based on MDD diagnostic criteria suggest
thatthesemeasurestapintodifferentcon-
structs that have independent associa-
tions with diabetes. For example, 70% of
diabetic patients with elevated self-
reported depressive symptom scores did
not meet diagnostic criteria for MDD on
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(6). More importantly, depressive symp-
toms and diabetes distress, which shared
only 23% of their variance, were each as-
sociated with problematic diabetes self-
management, whereas MDD was not (6).
Asubsequentstudyfurtherdemonstrated
that diabetes distress covaried with hy-
perglycemia over time, but depressive
symptoms and MDD did not (7). Thus, it
appearsthatMDD,depressivesymptoms,
and diabetes distress are distinct con-
structs with independent relationships to
diabetes.
We believe that much of the overap-
plicationoftheMDDconceptualmodelto
the problem of distress in diabetes is
linked to the fact that the contemporary
diagnostic system for MDD is based only
on symptom assessment (number, dura-
tion, and degree of impairment) and ig-
nores the life context in which these
symptomsoccur.AsHorowitzandWake-
ﬁeld (13) compellingly argue, this repre-
sents a departure from a long-standing
history of thought, from Hippocrates to
Kraepelin, that emphasizes the impor-
tance of situational context in the diagno-
sis of clinical depression. Evaluating
symptoms only, regardless of their deri-
vation (e.g., diabetes, job loss, divorce),
may improve the reliability of diagnosis,
butitsacriﬁcesvalidityandobfuscatesthe
great heterogeneity of presentations that
are, in our view, often misclassiﬁed as
MDD (leading inexorably, as we discuss
below, to inappropriate treatments).
This symptom-based and context-
neutral approach to conceptualizing and
assessing MDD is particularly problem-
atic for patients with diabetes, leading to
bothanoverpathologizingofpatientsand
an underappreciation of the role of
chronic illness in explaining emotional
symptoms.Forexample,inawell-deﬁned
sample of patients with diabetic periph-
eral neuropathy, investigators showed
that objective indicators of neuropathy
severity, neuropathy-related symptoms,
impairment in daily activities due to neu-
ropathy and neuropathy-related changes
in important roles were predictive of in-
creases in depressive symptoms over time
(14). Thus, a cascade of disease-related
factors,fromobjectiveindicatorsofsever-
ity to subjective ratings of functional
impairment, contributed to the develop-
mentofdepressivesymptomsinthesepa-
tients. Applying the label of MDD to the
outcome of these studies would not only
inaccurately pathologize the observed
level of depressive symptoms, it would
also ignore the disease-associated factors
that explain them.
The importance of disease-associated
functional impairment, in particular, as a
contributor to distress in chronic illness
has strong empirical support. For exam-
ple, disease-related physical limitations
predict changes in subsequent depressive
symptoms over time, but depressive
symptoms do not predict corresponding
changes in physical limitations (15). Fur-
thermore, although epidemiological data
consistently link MDD and physical ill-
ness, the strength of this association di-
minishes with age; impairments at young
ages of adulthood are more strongly asso-
ciated with MDD than those occurring at
advanced ages, when some loss in func-
tioning is normative and expected (16).
The link between chronic illness and de-
pressive symptoms similarly diminishes
with age, as does the association between
functional disability and depressive
symptoms (17). Thus, life context (e.g.,
expectations of functioning in important
roles) is crucial for explaining the link be-
tween disease and signiﬁcant emotional
distress. The current MDD-focused
model ignores this context and when ap-
plied to patients with diabetes leads to an
underappreciation of the impact of de-
manding treatment regimens, ongoing
threats of serious complications, and as-
sociated functional impairment that may
contribute to the experience of distress.
Have we been using the wrong
treatment approach?
The implications of this argument go far
beyond questions of semantics; the over-
application of the MDD-model to the
problem of distress in people with diabe-
tes has also led to a narrow focus on treat-
ments for clinical depression that may
not be appropriate for the majority of
distressed patients. For example, meta-
analysis has demonstrated that antide-
pressants, though widely prescribed as a
treatment for MDD, may be no more ef-
fective than placebo for mild to moderate
levels of symptom severity; clinically sig-
niﬁcant beneﬁts are only observed at
“very severe” levels of impairment (18).
Thus, exporting existing treatments for
MDDtothegreaterpopulationofdiabetic
patients experiencing disease-related dis-
tress or depressive symptoms may be ill
advised. Interventions that have at-
tempted this among those with diabetes
havefocusedrathernarrowlyonreducing
the severity of MDD with antidepressants
or psychotherapy and, for the most part,
have not attended to the co-occurring,
linked problems of living with and man-
aging the stress of diabetes. Moreover,
they have failed to show compelling evi-
dence that amelioration of MDD leads to
improved diabetes management or glyce-
mic control (9).
Newer intervention approaches re-
ﬂect an evolution in MDD-focused treat-
ment by concurrently addressing co-
occurring problems with diabetes
management. These include interven-
tions that integrate psychological treat-
ments with exercise training (20), nurse-
led self-management support (21), and
nurse-, dietitian-, and mental health-
specialist–delivered self-management in-
terventions (22). In contrast to previous
intervention studies that focused solely
ontheameliorationofMDD,thesestudies
also address the behavioral barriers to
successful diabetes treatment and, there-
fore, may be more successful in improv-
ing diabetes health outcomes. Novel
approachestotheemotionalaspectsofdi-
abetesmanagementareclearlyneededfor
thefarlargerpopulationofpatientsstrug-
glingwithdiabetes-relateddistressand/or
depressive symptoms but who are not
clinically depressed.
Although very few intervention stud-
ies have targeted diabetes distress di-
rectly, several trials have attempted to
integrate behavioral and distress-related
changes into a single, comprehensive in-
tervention. For example, a small trial of
cognitive behavioral therapy adapted to
address diabetes-relevant behavior
change improved both glycemic control
anddiabetesdistressinadultswithpoorly
controlled type 1 diabetes, compared
with a control condition, with beneﬁts
maintained over 1 year of follow-up (23).
Similar beneﬁts were seen from a peer-
delivered self-management intervention
in Spanish-speaking type 2 diabetic pa-
tients: both glycemic control and diabe-
tes-related distress improved relative to
control subjects, and improvements were
maintained over 18 months (24). These
studies suggest that co-occurring im-
provements in disease management and
diabetes distress can be achieved through
interventions that target both of these
linked problems.
Recommendations for clinical
practice: toward a new model of care
It is time to recognize that the marked
emotional distress commonly seen in pa-
tients with diabetes may not be a tradi-
tional depressive disorder, no matter the
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sionquestionnairenorthepresentationof
recognizable MDD symptoms. A new
treatment model to understand and ad-
dress the emotional concomitants of dia-
betes is needed. Diabetes-related distress
and depressive symptoms are clearly as-
sociated with problems of poor diabetes
self-management and clinical outcomes
and, therefore, should be recognized as
important indicators of diabetes self-
management. This is consistent with
dominant theories on the functional im-
plications of emotion, which argue that
emotions, both positive and negative,
serve to indicate how well a behavior is
leading to a desired outcome or goal (25).
Conceptualizing emotional distress
withinthecontextoftheself-regulationof
diabetes management supports interven-
tionapproachesthattargetproblemswith
self-management, including addressing
dysfunctional beliefs about diabetes and
reducing the tendency to disengage from
the pursuit of goals when experiencing
emotionaldistress,ratherthantreatments
that focus exclusively on reducing symp-
tomsofdistressdisconnectedfromthedi-
abetes-relevant issues that prompt them
(10).
This comprehensive approach to the
management of diabetes and nonpsychi-
atric emotional distress (including de-
pressive symptoms and diabetes-related
distress) requires several changes to how
we deliver care to patients with diabetes.
First, emotional distress should be con-
sidered a common component of the ex-
perience of diabetes; it falls within the
spectrum of diabetes management and is
notacomorbiddisorder.Second,because
of the reciprocal inﬂuences between
emotional distress and diabetes self-
management, distress can indicate in-
creasedriskforpoortreatmentoutcomes;
interventions that focus on addressing
both distress and diabetes management
are likely to have stronger effects than
those that focus on either in isolation
(21). Understanding the diabetes-related
factors that drive the experience of dis-
tress is crucial to the development of ap-
propriate interventions. Third, levels
of distress can vary considerably over
time, following or preceding changes in
diabetes status, and should be evaluated
regularly as part of ongoing, comprehen-
sivediabetescare.Fourth,therearemajor
advantagestotreatingthelargenumberof
distressed patients within the diabetes
practice environment rather than refer-
ring them to other health care providers:
comprehensive approaches to care that
recognize the bidirectional relationship
between distress and diabetes manage-
ment are likely to have maximal effects.
Although validated and easy-to-use
screening instruments for diabetes-related
distress are presently available (25,26), an
ongoingclinicalconversationaboutdistress
maybethemosteffectiveandtime-sensitive
clinical approach. It avoids false-positives
and over-pathologizing common nonpsy-
chiatric distress that can occur with many
screening instruments designed to detect
MDD and allows for the evaluation of the
context that might explain any distress that
is reported. The results of a brief conversa-
tion can also guide the selection of appro-
priate intervention. Patients reporting
distress secondary to frustration about
chronic hyperglycemia or fear of complica-
tions (i.e., diabetes-related distress) will
likely need different interventions than pa-
tients who report being distressed because
of life circumstances unrelated to diabetes.
Although antidepressants are unlikely to be
effective in most presentations of distress
(18), physical activity, psychotherapeutic
approaches, and discussions with diabetes
team members can be effective. Patients are
often relieved when health care providers
initiate discussions about their distress.
Even brief conversations that label feelings,
link them to difﬁculties with self-
management and normalize emotional re-
actionstodiabetesissuescanbere-assuring;
indeed, even the patient’s verbalization and
expression of emotional experiences of dia-
betes can be therapeutic.
While this comprehensive approach
totheassessmentandmanagementofdis-
tress in diabetes has clear advantages over
the current fragmented model of care in
the U.S., it may conﬂict with the existing
realities of treatment delivery. The time
pressures of clinical care may leave prac-
titioners unwilling to add tasks to an al-
ready densely packed clinical encounter.
Furthermore, many diabetes team mem-
bers may be uncomfortable addressing
the emotional components of diabetes
care, and may be concerned about open-
ing a Pandora’s Box that they fear will be
difﬁculttoclose.Webelievethataddress-
ing the emotional aspects of living with
diabetes does not require extensive
mental health training, although some
patients, especially those who are experi-
encing MDD or profound and longstand-
ing depressive symptoms or diabetes
distress,mayrequireareferralforspecial-
ized care. Rather, all team members
should be skilled in attentive and em-
pathic listening, sensitive verbal inquiry,
and use of thoughtful and reﬂective com-
ments—skills that are the hallmarks of
good clinical care. Documentation of the
content and level of distress that include
summaries of discussions among team
members as part of clinical care requires
only a small shift in perspective. A com-
prehensive approach that distinguishes
clinical depression from disease-related
distress and that offers support for the
management of emotional distress as an
integral part of providing support for the
behavioral management of diabetes will
have the greatest likelihood of clinical
beneﬁt for the vast majority of patients
with diabetes.
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